294 related articles for article (PubMed ID: 6219052)
21. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
Spicer BA; Ross JW; Smith H
Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
[TBL] [Abstract][Full Text] [Related]
22. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
Omote M; Sakai K; Mizusawa H
Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
[TBL] [Abstract][Full Text] [Related]
23. [Action of piroxicam on allergic inflammation].
Abe N; Tanaka K; Kanaoka K; Egawa M; Watanabe I; Hirai S
Nihon Yakurigaku Zasshi; 1983 May; 81(5):431-40. PubMed ID: 6629214
[TBL] [Abstract][Full Text] [Related]
24. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
[TBL] [Abstract][Full Text] [Related]
25. Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.
Braga F; Mota I
Immunology; 1976 May; 30(5):655-69. PubMed ID: 179937
[TBL] [Abstract][Full Text] [Related]
26. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
Goto K; Osuga K; Haga K; Tsumagari T
Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of methanolic extract from corydalis tuber against types I-IV allergic models.
Matsuda H; Tokuoka K; Wu J; Tanaka T; Kubo M
Biol Pharm Bull; 1995 Jul; 18(7):963-7. PubMed ID: 7581251
[TBL] [Abstract][Full Text] [Related]
28. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological actions of oxatomide (KW-4354). 3. Actions on experimental asthma and Schultz-Dale reaction].
Ohmori K; Ishii H; Takei Y; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):481-93. PubMed ID: 6131021
[TBL] [Abstract][Full Text] [Related]
30. [Effect of neurotropin (NSP) on allergic reactions (author's transl)].
Koda A; Nagai H; Kurimoto Y; Yamada T; Mori H; Nishiyori T; Inagaki N
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):319-34. PubMed ID: 6173291
[TBL] [Abstract][Full Text] [Related]
31. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
[TBL] [Abstract][Full Text] [Related]
32. [Effects of ferulic acid on allergic reaction].
Hu HJ; Hang BQ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
[TBL] [Abstract][Full Text] [Related]
33. Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs.
Goto K; Terasawa M; Kadobe Y; Maruyama Y
Jpn J Pharmacol; 1980 Aug; 30(4):537-47. PubMed ID: 6162988
[TBL] [Abstract][Full Text] [Related]
34. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
35. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
[TBL] [Abstract][Full Text] [Related]
36. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
Miller P; James GW
Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
39. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
[TBL] [Abstract][Full Text] [Related]
40. Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.
Hiroi J; Ohara K; Kobayashi K; Fujitsu T; Fujii T; Motoyama Y; Mori J; Shibayama F
Jpn J Pharmacol; 1988 Apr; 46(4):337-48. PubMed ID: 2457128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
